Nasdaq: ATRC

AtriCure, Inc. (ATRC)

AtriCure, Inc. is a public company that reports to the U.S. Securities and Exchange Commission and trades on Nasdaq under the ticker ATRC. Bright Analyst brings its financial statements, SEC filings, stock performance, news and peer comparisons together in one place, with AI analysis throughout.

Key facts

Ticker symbol
ATRC
Exchange
Nasdaq
SEC CIK
1323885
Official filings
SEC EDGAR

Research ATRC

  • Profile — Business description, headquarters, subsidiaries and corporate identifiers.
  • Financials — Income statement, balance sheet and cash flow from 10-K and 10-Q filings.
  • SEC Filings — Every 10-K, 10-Q and 8-K, readable inline with AI analysis.
  • Stock Analysis — Price chart, returns, technical indicators and related companies.
  • News — Latest headlines and press coverage.
  • Material Contracts — Material agreements filed as exhibits to SEC reports.
  • Benchmark — Stock performance against the S&P 500, Nasdaq-100 and Dow (through SPY, QQQ and DIA) and economic indicators.
  • Peer Comparison — Side-by-side financial ratios against industry peers.

Frequently asked questions

What is AtriCure, Inc.'s stock ticker?

AtriCure, Inc. trades under the ticker symbol ATRC on Nasdaq. Its SEC Central Index Key (CIK) is 1323885.

Where can I read AtriCure, Inc.'s SEC filings?

The ATRC SEC Filings page lists the 10-K annual reports, 10-Q quarterly reports and 8-K current reports AtriCure, Inc. has filed, with AI analysis. The original documents are also on SEC EDGAR.

How can I analyze ATRC's financial statements?

The ATRC Financials page shows AtriCure, Inc.'s income statement, balance sheet and cash flow statement, annual and quarterly, taken from its XBRL filings, with an AI analysis of each statement.

How does ATRC compare with its peers and the market?

The ATRC Peer Comparison page lines AtriCure, Inc. up against industry peers on valuation, growth and profitability ratios, and the Benchmark page compares its stock with the S&P 500, the Nasdaq-100 and the Dow.

For information only — not investment advice.